Bayer Budgets $2B To Settle Future Roundup Cancer Claims

By Mike Curley (November 3, 2020, 4:19 PM EST) -- Monsanto's parent company Bayer AG said Tuesday it expects to pay $2 billion in a class settlement to resolve future claims that Roundup weedkiller causes cancer, increasing its original estimate of $1.25 billion.

In an earnings report, the company said while it will take more time to complete the settlement process, it is far enough along to know the plan will cost about $2 billion, adding that it will file a motion for preliminary approval once a formal agreement is reached.

The deal is separate from a larger settlement the company announced in June to resolve claims in the sprawling multidistrict...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!